Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network
- PMID: 33434654
- DOI: 10.1016/j.cgh.2021.01.011
Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network
Abstract
Background: Herbal and dietary supplements (HDS) consumption, a growing cause of hepatotoxicity, is a common practice among Latin-American populations.
Objectives: To evaluate clinical, laboratory features and outcome in HDS-hepatotoxicity included in the Latin America-Drug Induced Liver Injury (LATINDILI) Network.
Methods: A total of 29 adjudicated cases of HDS hepatotoxicity reported to the LATINDILI Network from October 2011 through December 2019 were compared with 322 DILI cases due to conventional drugs and 16 due to anabolic steroids as well as with other series of HDS-hepatotoxicity.
Results: From 367 DILI cases, 8% were attributed to HDS. An increasing trend in HDS-hepatotoxicity was noted over time (p = .04). Camellia sinensis, Herbalife® products, and Garcinia cambogia, mostly used for weight loss, were the most frequently adjudicated causative agents. Mean age was 45 years (66% female). Median time to onset was 31 days. Patients presented typically with hepatocellular injury (83%) and jaundice (66%). Five cases (17%) developed acute liver failure. Compared to conventional medications and anabolic steroids, HDS hepatotoxicity cases had the highest levels of aspartate and alanine transaminase (p = .008 and p = .021, respectively), had more re-exposure events to the culprit HDS (14% vs 3% vs 0%; p = .026), and had more severe and fatal/liver transplantation outcomes (21% vs 12% vs 13%; p = .005). Compared to other DILI cohorts, less HDS hepatotoxicity cases in Latin America were hospitalized (41%).
Conclusions: HDS-hepatotoxicity in Latin-America affects mainly young women, manifests mostly with hepatocellular injury and is associated with higher frequency of accidental re-exposure. HDS hepatotoxicity is more serious with a higher chance of death/liver transplantation than DILI related to conventional drugs.
Keywords: Drug-Induced Liver Injury; Hepatotoxicity; Herbal and Dietary Supplements; Herbal-Induced Liver Injury; LATINDILI Network; Latin America; Liver Toxicity.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.
Comment in
-
Liver Injury After Dietary Supplements in Patients Living With HIV: A Call to Action.Clin Gastroenterol Hepatol. 2022 Jan;20(1):243-244. doi: 10.1016/j.cgh.2021.02.031. Epub 2021 Feb 20. Clin Gastroenterol Hepatol. 2022. PMID: 33621669 No abstract available.
Similar articles
-
Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network.Clin Gastroenterol Hepatol. 2025 Jan;23(1):89-102. doi: 10.1016/j.cgh.2024.06.030. Epub 2024 Jul 9. Clin Gastroenterol Hepatol. 2025. PMID: 38992407
-
Profile of herbal and dietary supplements induced liver injury in Latin America: A systematic review of published reports.Phytother Res. 2021 Jan;35(1):6-19. doi: 10.1002/ptr.6746. Epub 2020 Jun 11. Phytother Res. 2021. PMID: 32525269
-
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.Clin Gastroenterol Hepatol. 2018 Sep;16(9):1495-1502. doi: 10.1016/j.cgh.2017.12.051. Epub 2018 Jan 4. Clin Gastroenterol Hepatol. 2018. PMID: 29307848
-
The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware.Drug Saf. 2017 Sep;40(9):783-787. doi: 10.1007/s40264-017-0547-9. Drug Saf. 2017. PMID: 28555362 Free PMC article.
-
Severe liver injury due to herbal and dietary supplements and the role of liver transplantation.World J Gastroenterol. 2019 Dec 14;25(46):6704-6712. doi: 10.3748/wjg.v25.i46.6704. World J Gastroenterol. 2019. PMID: 31857773 Free PMC article. Review.
Cited by
-
Herbal and dietary supplement induced liver injury leading to hepatitis-associated severe aplastic anemia: A case report.JPGN Rep. 2024 Feb 12;5(2):208-212. doi: 10.1002/jpr3.12041. eCollection 2024 May. JPGN Rep. 2024. PMID: 38756121 Free PMC article.
-
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet.Pharmacol Res. 2024 Feb;200:107046. doi: 10.1016/j.phrs.2023.107046. Epub 2023 Dec 28. Pharmacol Res. 2024. PMID: 38159783 Free PMC article.
-
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update.Hepatol Int. 2024 Apr;18(2):384-419. doi: 10.1007/s12072-023-10633-7. Epub 2024 Feb 24. Hepatol Int. 2024. PMID: 38402364
-
Challenges in herbal-induced liver injury identification and prevention.Liver Int. 2025 Mar;45(3):e16071. doi: 10.1111/liv.16071. Epub 2024 Aug 13. Liver Int. 2025. PMID: 39136211 Free PMC article. Review.
-
Anabolic steroid-associated liver injury.Clin Liver Dis (Hoboken). 2024 Jun 12;23(1):e0196. doi: 10.1097/CLD.0000000000000196. eCollection 2024 Jan-Jun. Clin Liver Dis (Hoboken). 2024. PMID: 38872787 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical